The dispute between ZTE and Samsung over their global cross-licensing agreement for standard-essential patents presents a good opportunity for European courts to raise their profile. Most recently, the UPC positioned itself as the voice of reason with a proposal for settlement. Simultaneoulsy, the court also promoted the Patent Mediation and Arbitration Centre, which began its work at the same time.

The Paris Court of Justice is also reinforcing its reputation as a hub for pharmaceutical disputes in the complex case involving the cancer drug Velcade with a balanced partial judgment. The dispute will keep the courts busy for some time to come.

Outside the courts, the trend of private equity investors pushing into the European IP market continues: Belgian flooring innovator i4F has launched House of IP, a private equity-backed vehicle looking to acquire patent attorney firms across Benelux and Germany.

And in case you missed it, this week saw the launch of JUVE Patent’s new PaceMaker newsletter, aimed at decision makers in leading patent practices and their teams. From now on, PaceMaker will be sent every Wednesday exclusively to paying subscribers. So if you haven’t subscribed yet, sign up for a 4-week free trial.

Enjoy this week's read,